Myelodysplastic syndromes, version 2.2017: Clinical Practice Guidelines in Oncology Journal Article
| Authors: | Greenberg, P. L.; Stone, R. M.; Al-Kali, A.; Barta, S. K.; Bejar, R.; Bennett, J. M.; Carraway, H.; De Castro, C. M.; Deeg, H. J.; DeZern, A. E.; Fathi, A. T.; Frankfurt, O.; Gaensler, K.; Garcia-Manero, G.; Griffiths, E. A.; Head, D.; Horsfall, R.; Johnson, R. A.; Juckett, M.; Klimek, V. M.; Komrokji, R.; Kujawski, L. A.; Maness, L. J.; O'Donnell, M. R.; Pollyea, D. A.; Shami, P. J.; Stein, B. L.; Walker, A. R.; Westervelt, P.; Zeidan, A.; Shead, D. A.; Smith, C. |
| Article Title: | Myelodysplastic syndromes, version 2.2017: Clinical Practice Guidelines in Oncology |
| Abstract: | The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a highly variable disease course. Diagnostic criteria to better stratify patients with MDS continue to evolve, based on morphology, cytogenetics, and the presence of cytopenias. More accurate classification of patients will allow for better treatment guidance. Treatment encompasses supportive care, treatment of anemia, low intensity therapy, and high-intensity therapy. This portion of the guidelines focuses on diagnostic classification, molecular abnormalities, therapeutic options, and recommended treatment approaches. |
| Keywords: | phase-iii; randomized; hematopoietic-cell transplantation; chronic; quality-of-life; colony-stimulating factor; bone-marrow-transplantation; acute myeloid-leukemia; myelomonocytic leukemia; world-health-organization; transfusion-dependent patients; conventional care regimens |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 15 |
| Issue: | 1 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2017-01-01 |
| Start Page: | 60 |
| End Page: | 87 |
| Language: | English |
| ACCESSION: | WOS:000392045900007 |
| PROVIDER: | wos |
| PUBMED: | 28040720 |
| DOI: | 10.6004/jnccn.2017.0007 |
| Notes: | Review -- Source: Wos |
